Amgen Licenses Stem Cell Growth Factors to ViaCell

By Business Review Editor

Pharma Deals Review: Vol 2004 Issue 44 (Table of Contents)

Published: 4 Feb-2004

DOI: 10.3833/pdr.v2004.i44.830     ISSN: 1756-7874

Section: Licensing

Fulltext:

Abstract

ViaCell licensed several stem cell growth factors from Amgen, in a deal that provides the world’s largest biotechnology company with the right to commercialize the cellular therapy products that result from the collaboration...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details